Skip to main
CCRN

CCRN Stock Forecast & Price Target

CCRN Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Bulls say

Cross Country Healthcare has demonstrated a stable gross margin of 20.0% for the most recent quarter, maintaining this figure from the previous quarter and surpassing estimated expectations. The announced acquisition by Aya Healthcare at $18.61 per share represents a substantial 67% premium to Cross Country's share price prior to the announcement, highlighting the perceived intrinsic value of the company. Additionally, the revised timeline for the transaction's closure to the second half of 2025 suggests strategic planning and confidence in Cross Country’s future financial performance.

Bears say

Cross Country Healthcare reported a significant decline in adjusted EBITDA, which fell 44% year-over-year to $8.6 million in Q1/25, despite exceeding estimates. The company's Q1/25 revenue of $293.4 million was not only below both internal and consensus estimates but also represented a substantial 23% year-over-year decrease, primarily attributed to ongoing weaker demand in the healthcare travel staffing sector. Additionally, following these disappointing results, the revenue estimate for 2025 was revised down to $1.166 billion, reflecting a 13.3% year-over-year decline from the previously anticipated figure.

CCRN has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 100% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cross Country Healthcare (CCRN) Forecast

Analysts have given CCRN a Hold based on their latest research and market trends.

According to 2 analysts, CCRN has a Hold consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $13.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $13.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cross Country Healthcare (CCRN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.